Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Growth

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -11.54-12.5144.9880.9850.75

What is the latest Core EBITDA Growth ratio of INDOCO REMEDIES ?

The latest Core EBITDA Growth ratio of INDOCO REMEDIES is -11.54 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-11.54
Mar2023-12.51
Mar202244.98
Mar202180.98
Mar202050.75

How is Core EBITDA Growth of INDOCO REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -11.54
Negative
Mar2023 -12.51
Negative
Mar2022 44.98
-44.46
Mar2021 80.98
59.57
Mar2020 50.75 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,680.3 Cr -8.3% -10.8% -5.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,478.0 Cr -6.5% -4.7% -5.1% Stock Analytics
DIVIS LABORATORIES ₹162,845.0 Cr -7.1% -11.5% 32.7% Stock Analytics
CIPLA ₹120,121.0 Cr -4.3% -0.1% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,327.0 Cr -5.8% 6.1% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,907.8 Cr -5.8% -6.8% -11% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-8.3%

-10.8%

-5.8%

SENSEX

-1.2%

-3.5%

-0.5%


You may also like the below Video Courses